These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
368 related articles for article (PubMed ID: 25160988)
21. Identification and Characterization of NTB451 as a Potential Inhibitor of Necroptosis. In EJ; Lee Y; Koppula S; Kim TY; Han JH; Lee KH; Kang TB Molecules; 2018 Nov; 23(11):. PubMed ID: 30400632 [TBL] [Abstract][Full Text] [Related]
22. Necroptosis: a crucial pathogenic mediator of human disease. Choi ME; Price DR; Ryter SW; Choi AMK JCI Insight; 2019 Aug; 4(15):. PubMed ID: 31391333 [TBL] [Abstract][Full Text] [Related]
23. An immunohistochemical atlas of necroptotic pathway expression. Chiou S; Al-Ani AH; Pan Y; Patel KM; Kong IY; Whitehead LW; Light A; Young SN; Barrios M; Sargeant C; Rajasekhar P; Zhu L; Hempel A; Lin A; Rickard JA; Hall C; Gangatirkar P; Yip RK; Cawthorne W; Jacobsen AV; Horne CR; Martin KR; Ioannidis LJ; Hansen DS; Day J; Wicks IP; Law C; Ritchie ME; Bowden R; Hildebrand JM; O'Reilly LA; Silke J; Giulino-Roth L; Tsui E; Rogers KL; Hawkins ED; Christensen B; Murphy JM; Samson AL EMBO Mol Med; 2024 Jul; 16(7):1717-1749. PubMed ID: 38750308 [TBL] [Abstract][Full Text] [Related]
24. The Receptor Interacting Protein Kinases in the Liver. Dara L Semin Liver Dis; 2018 Feb; 38(1):73-86. PubMed ID: 29471568 [TBL] [Abstract][Full Text] [Related]
25. Necroptosis: the release of damage-associated molecular patterns and its physiological relevance. Kaczmarek A; Vandenabeele P; Krysko DV Immunity; 2013 Feb; 38(2):209-23. PubMed ID: 23438821 [TBL] [Abstract][Full Text] [Related]
26. RIPK3 promotes cell death and NLRP3 inflammasome activation in the absence of MLKL. Lawlor KE; Khan N; Mildenhall A; Gerlic M; Croker BA; D'Cruz AA; Hall C; Kaur Spall S; Anderton H; Masters SL; Rashidi M; Wicks IP; Alexander WS; Mitsuuchi Y; Benetatos CA; Condon SM; Wong WW; Silke J; Vaux DL; Vince JE Nat Commun; 2015 Feb; 6():6282. PubMed ID: 25693118 [TBL] [Abstract][Full Text] [Related]
28. RIPK1 can function as an inhibitor rather than an initiator of RIPK3-dependent necroptosis. Kearney CJ; Cullen SP; Clancy D; Martin SJ FEBS J; 2014 Nov; 281(21):4921-34. PubMed ID: 25195660 [TBL] [Abstract][Full Text] [Related]
30. New insights into the regulation of apoptosis, necroptosis, and pyroptosis by receptor interacting protein kinase 1 and caspase-8. Schwarzer R; Laurien L; Pasparakis M Curr Opin Cell Biol; 2020 Apr; 63():186-193. PubMed ID: 32163825 [TBL] [Abstract][Full Text] [Related]
31. Intracellular pH Regulates TRAIL-Induced Apoptosis and Necroptosis in Endothelial Cells. Zhang ZX; Gan I; Pavlosky A; Huang X; Fuhrmann B; Jevnikar AM J Immunol Res; 2017; 2017():1503960. PubMed ID: 28884134 [TBL] [Abstract][Full Text] [Related]
32. The Pathogenesis of Necroptosis-Dependent Signaling Pathway in Cerebral Ischemic Disease. Xu Y; Zhang J; Ma L; Zhao S; Li S; Huang T; Chu Z Behav Neurol; 2018; 2018():6814393. PubMed ID: 30140326 [TBL] [Abstract][Full Text] [Related]
33. Novel drug discovery strategies for atherosclerosis that target necrosis and necroptosis. Coornaert I; Hofmans S; Devisscher L; Augustyns K; Van Der Veken P; De Meyer GRY; Martinet W Expert Opin Drug Discov; 2018 Jun; 13(6):477-488. PubMed ID: 29598451 [TBL] [Abstract][Full Text] [Related]
37. Absence of RIPK3 predicts necroptosis resistance in malignant melanoma. Geserick P; Wang J; Schilling R; Horn S; Harris PA; Bertin J; Gough PJ; Feoktistova M; Leverkus M Cell Death Dis; 2015 Sep; 6(9):e1884. PubMed ID: 26355347 [TBL] [Abstract][Full Text] [Related]
38. The in vivo evidence for regulated necrosis. Tonnus W; Linkermann A Immunol Rev; 2017 May; 277(1):128-149. PubMed ID: 28462528 [TBL] [Abstract][Full Text] [Related]
39. Necroptosis is preceded by nuclear translocation of the signaling proteins that induce it. Yoon S; Bogdanov K; Kovalenko A; Wallach D Cell Death Differ; 2016 Feb; 23(2):253-60. PubMed ID: 26184911 [TBL] [Abstract][Full Text] [Related]